Tech Center 1600 • Art Units: 1621 1627 1628
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18271102 | METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO T CELL MEDIATED INTESTINAL DISORDERS | Non-Final OA | The Regents of the University of Michigan |
| 18727727 | GLYCOL COMPOSITIONS INCLUDING TOCOPHEROLS | Non-Final OA | Dow Global Technologies LLC |
| 17187880 | Early Stage Detection for Alzheimers and other Autoimmune Diseases | Final Rejection | VOC HEALTH, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy